<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04489277</url>
  </required_header>
  <id_info>
    <org_study_id>INSERM UMR_S 999</org_study_id>
    <nct_id>NCT04489277</nct_id>
  </id_info>
  <brief_title>Silent Brain Infarction After Endovascular Arch Procedures</brief_title>
  <official_title>Silent Brain Infarction After Endovascular Arch Procedures: Preliminary Results From the STEP Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Groupe Hospitalier Paris Saint Joseph</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is the largest study to evaluate incidence and distribution of silent cerebral
      infarction (SBI) following endovascular repair for disease of the aortic arch. Also, it is
      the first cohort to include total endovascular arch repair and devices flushed with carbon
      dioxide (CO2) to prevent gaseous cerebral embolization.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction. Poor data exist concerning the rate of silent cerebral ischemic events
      following endovascular treatment of the aortic arch. The objective of this work was to
      quantify these lesions using the STEP registry.

      Methods. This multicentre retrospective cohort study included consecutive patients treated
      with an aortic endoprosthesis deployed in Ishimaru zone 0 to 3 and brain diffusion-weighted
      magnetic resonance imaging (DW-MRI) within 7 days after the procedure. DW-MRI was performed
      to identify the location and number of new silent brain infarctions (SBI), microbleeds ans
      general outcome of the patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Actual">January 31, 2020</completion_date>
  <primary_completion_date type="Actual">January 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>17 Months</target_duration>
  <primary_outcome>
    <measure>frequency of silent cerebral infarcts on DW-MRI</measure>
    <time_frame>7 days</time_frame>
    <description>Primary outcomes were the frequency of silent cerebral infarcts on DW-MRI after endovascular arch procedures, and to identify the number, the distribution, and predictors of these lesions.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>perioperative ischemic stroke</measure>
    <time_frame>30 days</time_frame>
    <description>Secondary outcomes were perioperative ischemic stroke defined as a brain infarction of ischemic etiology which occurs during surgery or within 30 days after surgery, TIA, hemorrhagic stroke, 30-day mortality, spinal cord ischemia, length of stay and discharge disposition.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">91</enrollment>
  <condition>Aortic Arch Aneurysm</condition>
  <arm_group>
    <arm_group_label>Patients with Silent Brain Infarction</arm_group_label>
    <description>treated with an aortic endoprosthesis deployed in Ishimaru zone 0 to 3 and brain diffusion-weighted magnetic resonance imaging (DW-MRI) within 7 days after the procedure with silent brain infarction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients without Silent Brain Infarction</arm_group_label>
    <description>treated with an aortic endoprosthesis deployed in Ishimaru zone 0 to 3 and brain diffusion-weighted magnetic resonance imaging (DW-MRI) within 7 days after the procedure without silent brain infarction</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endovascular Arch Procedures</intervention_name>
    <description>Endovascular Arch Procedures (TEVAR, Branch endografts, Fenestrated endografts)</description>
    <arm_group_label>Patients with Silent Brain Infarction</arm_group_label>
    <arm_group_label>Patients without Silent Brain Infarction</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients, who received routine postoperative DW-MRI within 7 days after
        endovascular aortic arch repair between September 2018 and January 2020 at the University
        Hospital Hamburg-Eppendorf (Hamburg, Germany) and Marie Lannelongue Hospital (Paris,
        France) were identified.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Included patients underwent a proximal endograft deployment in Ishimaru zone 0 to 3

        Exclusion Criteria:

          -  Missing preoperative computed tomography angiography (CTA) scan of the chest and any
             circumstances that precluded the DW-MRI to be performed in the appropriate time
             window, such as a medical condition or an MRI contraindication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Marie Lannelongue Hospital (Paris, France)</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Hamburg-Eppendorf (Hamburg, Germany)</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 23, 2020</study_first_submitted>
  <study_first_submitted_qc>July 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2020</study_first_posted>
  <last_update_submitted>July 23, 2020</last_update_submitted>
  <last_update_submitted_qc>July 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Groupe Hospitalier Paris Saint Joseph</investigator_affiliation>
    <investigator_full_name>Wolf Eilenberg</investigator_full_name>
    <investigator_title>Professor Stephan Haulon, Proessor Tilo Kölbel</investigator_title>
  </responsible_party>
  <keyword>Thoracic endovascular aortic repair</keyword>
  <keyword>Silent cerebral infarction</keyword>
  <keyword>Stroke</keyword>
  <keyword>Magnetic resonance imaging</keyword>
  <keyword>DW-MRI</keyword>
  <keyword>Aortic arch disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Infarction</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

